Anti-PD-L1 treatment-induced genes relevant for autophagy and downregulated NF-κB-signaling, which is in line with data from a recent trial on triple-negative breast cancer cells, treated with Atezolizumab [52]. Here, CD274 is linked to triple-negative breast carcinoma.